Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EBIT (2019 - 2025)

Preaxia Health Care Payment Systems' EBIT history spans 7 years, with the latest figure at -$875203.0 for Q3 2025.

  • For Q3 2025, EBIT fell 18815.13% year-over-year to -$875203.0; the TTM value through Aug 2025 reached -$906959.0, down 1336.04%, while the annual FY2025 figure was -$152124.0, 52.97% down from the prior year.
  • EBIT for Q3 2025 was -$875203.0 at Preaxia Health Care Payment Systems, down from -$13463.0 in the prior quarter.
  • Across five years, EBIT topped out at -$4611.0 in Q2 2024 and bottomed at -$875203.0 in Q3 2025.
  • The 5-year median for EBIT is -$40317.0 (2021), against an average of -$79125.4.
  • The largest annual shift saw EBIT surged 88.69% in 2024 before it tumbled 18815.13% in 2025.
  • A 5-year view of EBIT shows it stood at -$43655.0 in 2021, then fell by 3.29% to -$45092.0 in 2022, then dropped by 0.04% to -$45109.0 in 2023, then soared by 69.7% to -$13666.0 in 2024, then crashed by 6304.24% to -$875203.0 in 2025.
  • Per Business Quant, the three most recent readings for PAXH's EBIT are -$875203.0 (Q3 2025), -$13463.0 (Q1 2025), and -$13666.0 (Q4 2024).